Thus, this study aimed to investigate whether multimodal MRI analysis enables differentiation of IDH mutation in patients with adult-type diffuse gliomas and methylation status of MGMT promoters in GBM patients and to establish non-invasive MRI imaging markers for preoperative stratification of high-risk molecular subtypes in adult-type diffuse gliomas. This evidence concerns the gene MGMT and glioblastoma.